Research Council Announcements: Grants

Grants announcements from the MassGeneral Hospital for Children Research Council.


MGHfC Sponsorship for Summer Program in Clinical Effectiveness

The MGHfC Department of Pediatrics will sponsor one scholarship for the 2015 Summer Program in Clinical Effectiveness. Deadline for applications is December 15th, 2014. Please provide a one page justification for the application including future plans, a letter from your Division Chief, and your curriculum vitae, and send electronically to Dr. W. Allan Walker ( A decision will be made by January 7th, 2015.

The Program in Clinical Effectiveness (PCE), a Joint Program of BWH, MGH, HMS and HSPH, is designed for physician-clinicians, fellows and faculty seeking the quantitative and analytic skills needed for clinical research or interested in health care administration. The 2015 program, which runs from July 1 to Aug. 15, is an intensive seven-week, 15-credit summer program, which contains summer-long core courses in Clinical Epidemiology and Biostatistics. All participants also select two half-summer courses from offerings in Current Issues in Health Policy, Decision Analysis in Clinical Research, Ethical Basis of the Practice of Public Health, Improving Quality in Health Care, Introduction to Methods and Applications in Health Services Research, Linear and Longitudinal Regression, Measuring and Analyzing the Outcomes of Health Care, Medical Informatics, Methods for Decision Making in Medicine, Research with Large Databases, and Research on Social and Behavioral Health: A Practical Guide. For students with previous experience, second level courses are also offered in Analytic Issues of Clinical Epidemiology, Principles of Clinical Trials, and Survival Methods in Clinical Research.



MGH ECOR Formulaic Bridge Funding


What is it? Formulaic Bridge Funding Support is offered to assist MGH Principal Investigators during a lapse or delay in their funding from NIH. To be eligible for Formulaic Bridge Funding, applicants must have applied as a PI for an R01 or R21 grant to support an independent, long-term research program.

The Formulaic Bridge process is open to:

1. Investigators whose grants received a score < or = 20th percentile and have received written communication from the NIH that the grant will not be funded.

2. Investigators whose grants received a fundable score (< or = 20th percentile) but are 3 months past the nominal start date of the the grant.


When is the deadline? 7th day of each month.


How do I learn more and apply? Click here to read more and apply online.
Visit the ECOR website and specifically the Formulaic Bridge Funding Support under the Awards and Grants tab of the site.




The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine

January 19, 2015 DEADLINE


The Office for Faculty Affairs is pleased to announce the release of the 2015 Shore Fellowship application.


The Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine seeks to support the academic success of junior faculty, women and men, at the most vulnerable point in their careers, namely, when young physicians and scientists must teach, do research, compete for grants, publish, and practice (if a clinical faculty member) at the same time they may be assuming increased family or other responsibilities.  Stipends of at least $25,000 may be used to buy protected time from clinical or laboratory responsibilities to pursue academic work, including writing a grant application, preparing a manuscript, completing a research project, or developing a new curriculum.  Funds awarded could also be used for additional laboratory assistance at a time when the junior faculty member does not yet have independent funding.


The program was renamed in 2004 to honor Doctors Eleanor and Miles Shore’s efforts on behalf of the 50th Anniversary Scholars in Medicine Fellowship program.





Please note that some fellowships have different application deadlines; please see website for details.


For questions,  please contact the Faculty Development Coordinator Megan Dross at (617) 432-1198 or




Harvard CFAR Feasibility Projects and Scholar Awards


The Harvard University Center for AIDS Research (HU CFAR) is pleased to announce a Request for Proposals for HIV/AIDS research for awards beginning April 1, 2015.


The HU CFAR welcomes proposals for Feasibility Projects and Scholar Awards for research in all disciplines, including but not limited to, one or more of the following: 


  • Behavioral and Social Sciences
  • Clinical Epidemiology and Outcomes Research
  • International Research
  • Pathogenesis
  • Therapeutics
  • Vaccine 


Download complete application PDF


Applications are due February 2, 2015 

at 4 PM



Massachusetts Life Sciences Center (MSLC) Cooperative Research Matching Grant Program

The Cooperative Research Matching Grant Program is designed to promote industry-academic research collaborations, support translational research, and accelerate the commercialization of promising products and services. Not-for-profit academic/research institutions are eligible to apply for grant funding of up to $250,000 per year over two years, provided that they have secured an industry sponsor for the research which will match MLSC funds on at least a 1:1 basis.

Applicants will be required to clearly identify the opportunity or value proposition for collaborating with the industry sponsor. Click here for more information. This program is now open for applications until February 13, 2015 at 12 noon EST.



Bill & Melinda Gates Foundation -- Grand Challenges Explorations


Bill & Melinda Gates Foundation is now inviting applications to Grand Challenges Explorations, which has awarded over 1070 grants in over 58 countries to date.

Grand Challenges Explorations seeks innovative global health and development solutions. Applicants can be at any experience level; in any discipline; and from any organization, including universities, government laboratories, research institutions, non-profit organizations as well as for-profit companies.


Two-page proposals for the following will be accepted until January 13, 2015:

Full descriptions of the new topics and application instructions are available at:





MGH Center for Human Immunology – P&F Grants


Applications are due December 12.


The Center for the Human Immunology (CHI) is a multidisciplinary program funded by NIAID.  CHI promotes the research of both basic and clinical scientists in areas related to the persistence of hepatitis C virus infection.  These include, but are not limited to:


  • Immune and Inflammatory Responses to Pathogens (including innate immune recognition and antigen presentation)
  • Viral Pathogenesis (including virus-host cell interactions, but related to the immune response)


Goals: Funds have been made available to support pilot/feasibility study grants consistent with the overall goals of the center.  The goals of the CHI Program are to support:


  • Young investigators (junior faculty or senior fellows*) working in areas that will improve our understanding of basic processes relevant to viral persistence. 
  • Established investigators initiating a new area of research in their laboratories relevant to mechanisms underlying viral persistence.


The objective of a pilot/feasibility study grant is to enable an investigator to complete sufficient preliminary studies to enable successful application for more substantial funding from other sources. Pilot/feasibility study grants are not intended to supplement ongoing or currently funded projects.  


Funding: The CHI will be funding grants of up to $50,000 direct costs through this program. Pilot/feasibility study awards are made for a one-year period; a second year may be considered on a competing basis. 


Applications: May be obtained by sending a request to Barbara Steele via telephone at 617-724-7554 or via email at  The deadline for receipt of applications is December 12.


* Fellow must be in the final year of training and must have a documented commitment to a faculty appointment by the sponsoring unit or department.  



Pilot Grant for Neurogenerative Diseases


The Massachusetts Alzheimer’s Disease Research Center (“MADRC”) and the Harvard NeuroDiscovery Center (“HNDC”) are co-funding novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community, including Harvard-affiliated hospitals and institutions. Grants with a dollar value up to $40,000 (direct costs) will be awarded for the duration of one year.  This award cycle anticipates funding between three and six awards.


More information may be found at


Applications due: December 10

Recipients announced: January 15, 2015


Awards start: April 1, 2015


HMS Foundation Funds

The Fall nominatino process for the 2014 HMS Foundation Funds is complete.  Please see the website for further details. 

If you are an MGH investigator, you should not apply directly to HMS for several of the funding opportunities offered through the HMS foundation funds annually. Please see the chart located here to determine where to apply and for information on the process.

If you have any questions, please contact Erin McGivney at 617-643-6471.



Limited Submission Funding Opportunities


We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include: 1. Name of the Principal Investigator with appropriate contact information 2. A descriptive title of the potential application 3. Brief description of the project 4. Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities  Please click here for more information and for our internal deadlines.

  • Clinical and Translational Science Award (U54)
  • NIH Director's Early Independence Awards (DP5) – NEW!


If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.


Private Funding Opportunities


Please contact Corporate & Foundation Relations in the Office of Development at if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

  •  Cassen Postdoctoral Mentoring Award, Education and Research Foundation for Nuclear Medicine and Molecular Imaging
  • Otolaryngical Development Awards, Triological Society

Please click here for further details on these funding opportunities.




Please click here to find current grant opportunities from the Patient-Centered Outcomes Research Institute.


NIH Funding Opportunities


The National Institutes of Health is challenging science innovators to compete for prizes totaling up to $500,000, by developing new ways to track the health status of a single cell in complex tissue over time. The NIH Follow that Cell Challenge seeks tools that would, for example, monitor a cell in the process of becoming cancerous, detect changes due to a disease-causing virus, or track how a cell responds to treatment. For more information, please click here.


For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link:


What will we discover next?

Learn how researchers at MassGeneral Hospital for Children are finding new treatments that advance pediatric care.